STEAP1, STEAP2, and STEAP4 have been evaluated as possible diagnostic and prognostic biomarkers in glioblastoma, breast cancer, Ewing sarcoma, lung cancer, and PCa [50,51,52,53,54]. This evidence concerns the gene STEAP4 and posterior cortical atrophy.